← Open Payments lookup

NATALIE TELLEZ: Open Payments

NPI 1730433947 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$208,686 in 452 payments from 18 companies in 2025. Trend: 2023 $152,264 · 2024 $146,440 · 2025 $208,686

Speaker / faculty: $164,560Travel & lodging: $34,536Food & beverage: $7,110Consulting: $2,480
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.161$94,701
ABBVIE INC.166$88,879
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)52$17,962
Otsuka America Pharmaceutical, Inc.29$6,128
Takeda Pharmaceuticals U.S.A., Inc.6$169
Neurocrine BioSciences, Inc.5$135
Alkermes, Inc.5$122
Lundbeck LLC4$108
Corium, LLC5$83
Axsome Therapeutics, Inc.3$70

Products named: FANAPT, VRAYLAR, CAPLYTA, REXULTI, TRINTELLIX, INGREZZA, ARISTADA, Azstarys.

Industry payments across TX — which companies pay providers there.